Genetics

This blog post examines the study by Kreft et al., which evaluated whether recently identified genetic variants associated with multiple sclerosis severity can predict long-term disease course in a real-world cohort. Although the rs10191329A variant has been proposed as a marker of faster disability progression, this independent analysis found no meaningful association with relapse activity, EDSS milestones, secondary progression, or age-related multiple sclerosis severity. The article highlights the current limitations of genetic prognostication in multiple sclerosis while emphasizing the importance of independent replication, refined clinical phenotyping, and integrated predictive models that combine genetics with clinical, imaging, and biomarker data.